ADMI
Albert D. Mason Inc’s Bristol-Myers Squibb BMY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $325K | Buy |
7,023
+60
| +0.9% | +$2.78K | 0.24% | 109 |
|
2025
Q1 | $425K | Sell |
6,963
-250
| -3% | -$15.2K | 0.29% | 102 |
|
2024
Q4 | $408K | Buy |
7,213
+41
| +0.6% | +$2.32K | 0.27% | 108 |
|
2024
Q3 | $371K | Hold |
7,172
| – | – | 0.24% | 115 |
|
2024
Q2 | $298K | Sell |
7,172
-35
| -0.5% | -$1.45K | 0.2% | 124 |
|
2024
Q1 | $391K | Buy |
7,207
+517
| +8% | +$28K | 0.24% | 120 |
|
2023
Q4 | $343K | Hold |
6,690
| – | – | 0.23% | 123 |
|
2023
Q3 | $388K | Sell |
6,690
-100
| -1% | -$5.8K | 0.28% | 120 |
|
2023
Q2 | $434K | Sell |
6,790
-985
| -13% | -$63K | 0.3% | 114 |
|
2023
Q1 | $539K | Sell |
7,775
-310
| -4% | -$21.5K | 0.37% | 103 |
|
2022
Q4 | $582K | Hold |
8,085
| – | – | 0.42% | 100 |
|
2022
Q3 | $575K | Buy |
8,085
+70
| +0.9% | +$4.98K | 0.46% | 88 |
|
2022
Q2 | $617K | Hold |
8,015
| – | – | 0.46% | 94 |
|
2022
Q1 | $585K | Buy |
8,015
+95
| +1% | +$6.93K | 0.38% | 113 |
|
2021
Q4 | $494K | Buy |
7,920
+2,580
| +48% | +$161K | 0.29% | 122 |
|
2021
Q3 | $316K | Buy |
5,340
+160
| +3% | +$9.47K | 0.2% | 139 |
|
2021
Q2 | $346K | Buy |
5,180
+265
| +5% | +$17.7K | 0.21% | 133 |
|
2021
Q1 | $310K | Buy |
4,915
+275
| +6% | +$17.3K | 0.2% | 130 |
|
2020
Q4 | $288K | Buy |
+4,640
| New | +$288K | 0.2% | 129 |
|